procarbazine has been researched along with Atypical Ductal Hyperplasia in 4 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We observed a linear radiation dose-response curve with an adjusted excess odds ratio (EOR) of 6." | 1.46 | Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure. ( Aleman, BMP; Broeks, A; De Bruin, ML; de Vathaire, F; Diallo, I; Fase, S; Hauptmann, M; Janus, CPM; Kesminiene, A; Kooijman, KR; Krol, ADG; Krul, IM; Lybeert, ML; Opstal-van Winden, AWJ; Russell, NS; Schaapveld, M; van der Maazen, RWM; van Eggermond, AM; van Leeuwen, FE; Zijlstra, JM, 2017) |
| "Ductal invasive carcinoma and ductal carcinoma in situ represented, respectively, 51 cases (71%) and 14 cases (19%)." | 1.38 | Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. ( Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D, 2012) |
| "Two patients developed breast cancer 14 and 8 years after treatment of Hodgkin's disease." | 1.29 | Breast cancer developing after therapy for Hodgkin's disease. ( Cascinu, S; Catalano, G; Fedeli, A, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krul, IM | 1 |
| Opstal-van Winden, AWJ | 1 |
| Aleman, BMP | 1 |
| Janus, CPM | 1 |
| van Eggermond, AM | 1 |
| De Bruin, ML | 1 |
| Hauptmann, M | 1 |
| Krol, ADG | 1 |
| Schaapveld, M | 1 |
| Broeks, A | 1 |
| Kooijman, KR | 1 |
| Fase, S | 1 |
| Lybeert, ML | 1 |
| Zijlstra, JM | 1 |
| van der Maazen, RWM | 1 |
| Kesminiene, A | 1 |
| Diallo, I | 1 |
| de Vathaire, F | 1 |
| Russell, NS | 1 |
| van Leeuwen, FE | 1 |
| Haberer, S | 1 |
| Belin, L | 1 |
| Le Scodan, R | 1 |
| Kirova, YM | 1 |
| Savignoni, A | 1 |
| Stevens, D | 1 |
| Moisson, P | 1 |
| Decaudin, D | 1 |
| Pierga, JY | 1 |
| Reyal, F | 1 |
| Campana, F | 1 |
| Fourquet, A | 1 |
| Bollet, MA | 1 |
| Neuwelt, EA | 1 |
| Hill, SA | 1 |
| Frenkel, EP | 1 |
| Cascinu, S | 1 |
| Fedeli, A | 1 |
| Catalano, G | 1 |
4 other studies available for procarbazine and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Breast; Breast Neoplasms; Carcinoma | 2017 |
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms | 2012 |
Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; B | 1984 |
Breast cancer developing after therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intr | 1993 |